Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria

Minerva Endocrinologica

Volumn 37, Issue 3, 2012, Pages 247-254

  Kocelak P ^a   Chudek, J ^a   Olszanecka Glinianowicz, M ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diagnosis; Insulin resistance; Metabolic syndrome X; Obesity

Indexed keywords

GLUCOSE; INSULIN; LIPID;

2009 IDF MODIFIED CRITERIA; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IDF 2005 CRITERIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NCEP ATP 3 CRITERIA; OBESITY; PREVALENCE; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; WHO CRITERIA;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; BODY HEIGHT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; POLAND; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE;

EID: 84867449014     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F-29F. (Pubitemid 29247378)
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
3. Rendell M, Hulthén UL, Törnquist C, Groop L, Mattiasson I. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab 2001;86:744-9. (Pubitemid 32207490)
4. Ruderman N, Chisholm D, Pi-Sunnyer X. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713. (Pubitemid 28201798)
5. Karelis AD, St Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004;89:2569-75. (Pubitemid 38766333)
6. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III - ATP III). JAMA 2001;285:2486-97.
7. th April 2005, www.idf.org
8. Alberti KGMM, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
9. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53. (Pubitemid 28319935)
10. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African-Americans: the Atherosclerosis Risk in Communities baseline study. Diabetes Care 1996;19:414-8. (Pubitemid 26143742)
11. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Schmidt MI et al. Familial components of the multiple metabolic syndrome: the ARIC study. Diabetologia 1997;40:963-70. (Pubitemid 27316579)
12. Grundy SM. Does the Metabolic Syndrome exist? Diabetes Care 2006; 29: 1689-1692. (Pubitemid 44127605)
13. Jonson LW, Weinstock RS. The metabolic syndrome: is it really a syndrome? Clin Cardiol 2006;29:523-4.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia.1985;28: 412-9. (Pubitemid 15018832)
15. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005;28:2745-9. (Pubitemid 43951170)
16. Li W, Xue H, Sun K, Song XD, Wang YB, Zhen YS, et al. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J (Engl) 2008;121:1532-6.
17. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J AM Col Surg 2008;207:928-34.
18. Wyrzykowski B, Zdrojewski T, Sygnowska E, Biela U, Drygas W, Tykarski A, et al. Epidemiology of metabolic syndrome in Poland. The results of WOBASZ program. Kardiol Pol 2005;63(Suppl.4):6.
19. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US populations from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36. (Pubitemid 36241019)
20. Chateau-Degat ML, Dewailly E, Poirer P, Gingras S, Egeland G. Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada. Met Clin Exp 2008;57:1526-32.
21. Nilsson G, Hedberg P, Jonason T, Lonnberg I, Tenerz A, Forberg R, Ohrvik J. Waist circumference alone predicts insulin resistance as good as the metabolic syndrome in elderly women. Eur J Int Med 2008;19:520-6.
22. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Trembley A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8. (Pubitemid 24096208)
23. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003;77:379-84. (Pubitemid 36133380)
24. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 2005;28:2322-5. (Pubitemid 41242490)
25. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US populations from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36. (Pubitemid 36241019)
26. Gonzales A, Guerrera DB, Soto M, Diaz PS, Luis D, Torre LM, et al. Does the prevalence of the metabolic syndrome improve by applying the International Diabetes Federation criteria? Public Health Nutr 2006;10.1173-80.
27. Molero-Conejo E, Morales LM, Fernandez V, Releigh X, Gomez ME, Semprun-Fereira M, et al. Lean adolescents with increased risk for metabolic syndrome. Arch. Latinoam. Nutr. 2003;53:427.
28. Orange MP, Janssen I, Heynsfield SB. Metabolic syndrome in normal weight Americans. New definitions of metabolically obese, normal weight individuals. Diabetes Care 2004;27:2222-8.
29. Conus F, Allison DB, Raabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-20. (Pubitemid 39391442)
30. Tarantino G. Should nonalcoholic fatty liver disease be regarded as a hepatic illness only? World J Gastroenterol 2007;13:4669-72. (Pubitemid 47455557)
31. Tarantino G, Colicchio P, Conca P, Finelli C, Minno M, Tarantino M, et al. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? Inflamm 2009,6:6-12.
32. Tarantino G, Conca P, Riccio A, Tarantino M, Di Minno M, Chianese D, et al. Enhanced serum concentrations of transforming growth factor-beta 1 in simple fatty liver: is it really benign? J Transl Med 2008;6:72-9.